Follow The Filings

NKTR position history

The shares of Nektar Therapeutics (NKTR) that DAFNA Capital Management LLC reported in each quarter’s 13F.

Equity, COM NEW

Shares held by quarter

New Add Reduce Exit

  1. 2025 Q2: 10,000 shares, $258K, 0.07% of portfolio, New
  2. 2025 Q3: 54,998 shares, $3.1M, 0.77% of portfolio, Add +450.0%
  3. 2025 Q4: 74,998 shares, $3.2M, 0.74% of portfolio, Add +36.4%
  4. 2026 Q1: 165,178 shares, $12M, 2.7% of portfolio, Add +120.2%
  5. 2026 Q2: 318,380 shares, $22M, 4.2% of portfolio, Add +92.7%
  6. 2026 Q3: 323,380 shares, $20M, 4.2% of portfolio, Add +1.6%
Holdings date Value % of holdings Shares Filing date All 13F holders